Start with the direction of the hypothesis
CRISPR interference lowers gene expression; CRISPR activation raises it. Both can help test how gene activity contributes to cellular behavior. The relevant question is not simply whether a gene is associated with aging, but whether a particular direction of change improves the chosen function in the relevant model.
Deleting a gene with a nuclease is another intervention again. Repression, activation, deletion and separation of one protein interaction should not be collapsed into the same evidence label.
An activation result needs its safeguards
The assessment describes CRISPRa activation of endogenous POLR2A alleviating senescent phenotypes in a cellular system. That is a context-specific result involving a pathway connected with MDM4, p53 and p21—not a recommendation to bypass protective growth controls.
SRSF1 belongs in a different category: the cited study used a cDNA overexpression screen, not CRISPR. Testing whether controlled CRISPRa could reproduce a useful result would be a new hypothesis, not a completed experiment.
A reduction can help—or harm
The GNPTAB assessment emphasizes a selective interaction question: an unwanted signaling function might be separable from essential maintenance. That does not justify indiscriminate reduction of the protein throughout the body.
The TOP2B promoter-deletion study offers a counterexample to simplistic rejuvenation logic: the edited HEK293T cells became senescent. Its immortalized cell model limits translation, but the direction of the result remains important.
Build a comparison that can inform a decision
A specialist-reviewed scope should state the model, intervention direction, functional readout, identity measurements, independent units, follow-up and interpretation limits. A lower senescence marker alone does not establish that surviving cells work better.
Use the method comparison tool to organize the choices, then qualify the actual scientific and laboratory work. The website tool does not design guides, rank them for clinical use or certify an intervention.
